With Patients’ Safety Top of Mind, Oncologists Develop Innovative Care Plans During PandemicMay 25th 2020
"Our efforts in the cancer clinic have been driven by patient safety and also maintaining patient access to care. In the age of COVID-19, those 2 things are sometimes at odds with each other."
Hitting the Target: Rapid Evolution of Plasma Assays Continues to Move Genomic Profiling Toward More Efficient Testing MethodsMay 20th 2020
"Liquid biopsy is useful at any time when a physician needs genomic information about their patient’s cancer in order to make a treatment decision."
Oncogene Identification and Treatment Advances Guide Lung Cancer MeetingMay 13th 2020
With the identification of new oncogenes leading to the development of drugs that target mutations, lung cancer can now be considered a treatable disease. In addition to advances in therapy, improved tumor testing can help the oncologist develop a personalized approach to treating patients.
Protocol Management, Off-the-Shelf Therapies Help Bring CAR T Into More SettingsMay 12th 2020
Relevant professional meetings and oncology publications exploded with research and news about chimeric antigen receptor T cells, and this cellular therapy strategy is now being explored across hematologic and solid malignancies.